Literature DB >> 10067669

The introduction of new vaccines into developing countries.

R T Mahoney1, J E Maynard.   

Abstract

The development and introduction of new vaccines is a costly and time consuming process. Unfortunately, those most in need--individuals in developing countries--are the last to receive these powerful disease preventing products. From the time a vaccine is first licensed in a developed country to the time most of the poor in developing countries have access to the vaccine can be 20-30 years. This delay is unacceptable. There is a great need to reduce this time span. This paper examines five ways of reducing the time span. Each of the five is essential and achieving success on all five will require a heightened level of international effort and coordination.

Mesh:

Substances:

Year:  1999        PMID: 10067669     DOI: 10.1016/s0264-410x(98)00246-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

Review 1.  Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas.

Authors:  G William Letson; Pratap Singhasivanon; Eduardo Fernandez; Nihal Abeysinghe; Juan Jose Amador; Harold S Margolis; Robert Edelman
Journal:  Hum Vaccin       Date:  2010-10-01

2.  Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).

Authors:  Gian Gandhi
Journal:  BMC Public Health       Date:  2015-11-30       Impact factor: 3.295

3.  Ensuring access to HPV vaccines through integrated services: a reproductive health perspective.

Authors:  Amy E Pollack; Miranda Balkin; Lindsay Edouard; Felicity Cutts; Nathalie Broutet
Journal:  Bull World Health Organ       Date:  2007-01       Impact factor: 9.408

Review 4.  Vaccines to combat the neglected tropical diseases.

Authors:  Jeffrey M Bethony; Rhea N Cole; Xiaoti Guo; Shaden Kamhawi; Marshall W Lightowlers; Alex Loukas; William Petri; Steven Reed; Jesus G Valenzuela; Peter J Hotez
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries.

Authors:  Eric J Suba; Sean K Murphy; Amber D Donnelly; Lisa M Furia; My Linh D Huynh; Stephen S Raab
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

Review 6.  Development of orphan vaccines: an industry perspective.

Authors:  J Lang; S C Wood
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

7.  Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan.

Authors:  Najwa Khuri-Bulos; John V Williams; Asem A Shehabi; Samir Faouri; Ehsan Al Jundi; Omar Abushariah; Qingxia Chen; S Asad Ali; Sten Vermund; Natasha B Halasa
Journal:  Scand J Infect Dis       Date:  2010-05

Review 8.  Enhancing vaccine safety capacity globally: A lifecycle perspective.

Authors:  Robert T Chen; Tom T Shimabukuro; David B Martin; Patrick L F Zuber; Daniel M Weibel; Miriam Sturkenboom
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

Review 9.  Health economics of dengue: a systematic literature review and expert panel's assessment.

Authors:  Mark E Beatty; Philippe Beutels; Martin I Meltzer; Donald S Shepard; Joachim Hombach; Raymond Hutubessy; Damien Dessis; Laurent Coudeville; Benoit Dervaux; Ole Wichmann; Harold S Margolis; Joel N Kuritsky
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

10.  Community perceptions of malaria and vaccines in the South Coast and Busia regions of Kenya.

Authors:  David I Ojakaa; Peter Ofware; Yvonne W Machira; Emmanuel Yamo; Yvette Collymore; Antoinette Ba-Nguz; Preeti Vansadia; Allison Bingham
Journal:  Malar J       Date:  2011-05-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.